CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
At week 24 in the CORALreef Lipids and CORALreef HeFH trials, Merck's LIPFENDRA significantly reduced LDL-C by a placebo-adjusted 56% and 59%, respectively.
At week 24 in the CORALreef Lipids and CORALreef HeFH trials, Merck's LIPFENDRA significantly reduced LDL-C by a placebo-adjusted 56% and 59%, respectively.
Serotonin is usually associated with mood, sleep, and digestion. But research published in 2023 suggests this chemical messenger may also influence a small structure that performs a vital job during every heartbeat: the mitral valve.
The...
Serotonin is usually associated with mood, sleep, and digestion. But research published in 2023 suggests this chemical messenger may also influence a small structure that performs a vital job during every heartbeat: the mitral valve.
The...
Given the availability of safer technologies, the authors say broader implementation of enhanced radiation protection devices (ERPDs) is both an ethical responsibility and a necessary evolution of ALARA (“As Low As Reasonably Achievable”),...
Given the availability of safer technologies, the authors say broader implementation of enhanced radiation protection devices (ERPDs) is both an ethical responsibility and a necessary evolution of ALARA (“As Low As Reasonably Achievable”),...
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
CHULA VISTA, CA. — The Society of Cardiovascular Computed Tomography (SCCT) announced its best original science award winners of the 21st Annual Scientific Meeting (SCCT2026) in San Diego, Calif.
The SCCT Best Abstract Award – supported by...
CHULA VISTA, CA. — The Society of Cardiovascular Computed Tomography (SCCT) announced its best original science award winners of the 21st Annual Scientific Meeting (SCCT2026) in San Diego, Calif.
The SCCT Best Abstract Award – supported by...
Data from one of the first studies in long-segment (>30 cm) FP disease show durable patency, low reintervention rate, and high limb salvage through 36 months.
Data from one of the first studies in long-segment (>30 cm) FP disease show durable patency, low reintervention rate, and high limb salvage through 36 months.
ALAMEDA, Calif. - Penumbra, Inc. announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer...
ALAMEDA, Calif. - Penumbra, Inc. announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer...
SAN CLEMENTE, CA — Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported...
SAN CLEMENTE, CA — Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported...
